Atkore Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Atkore Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	1,523	1,504	1,835	1,917	1,765	2,928	3,914	3,519	3,202	2,850
Cost of revenue	1,156	1,143	1,397	1,419	1,274	1,802	2,274	2,179	2,124	2,174
Gross profit	368	361	438	497	491	1,126	1,640	1,340	1,078	676
Selling, general and administrative	220	183	226	241	219	293	370	388	398	397
Operating income	125	156	180	224	240	799	1,234	893	625	23.2
Other non-operating income	1.45	6.58	27.3	11.5	2.78	18.2	0.49	-7.97	-1.96	-7.7
Pre-tax income	86.8	126	166	185	202	780	1,204	850	587	-18.6
Income tax	28	41.5	29.7	45.6	49.7	192	290	160	114	-3.42
Net income	58.8	84.6	137	139	152	588	913	690	473	-15.2
EBITDA	180	211	247	296	314	878	1,318	1,009	746	148
EPS, basic	0.94	1.33	2.59	2.91	3.15	12.38	20.56	17.51	12.83	-0.45
EPS, diluted	0.94	1.27	2.48	2.83	3.10	12.19	20.30	17.27	12.69	-0.45
Shares, basic (weighted)	62.5	63.4	51.8	46.6	47.3	46.6	43.7	38.8	36.4	34
Shares, diluted (weighted)	62.8	66.6	54.1	47.8	48	47.3	44.3	39.3	36.8	34

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	200	45.7	127	123	284	576	389	388	351	507
Receivables	192	224	265	315	298	525	529	560	490	447
Inventory	161	200	222	226	199	286	455	494	525	485
Other current assets	22.4	35.6	33.6	34.7	46.9	34.2	80.7	96.7	158	82.7
Total current assets	583	506	647	700	829	1,421	1,453	1,538	1,524	1,601
Property, plant and equipment	203	209	213	261	244	276	390	559	652	594
Lease right-of-use assets					37.7	38.6	68.7	118	171	147
Goodwill	116	148	170	186	188	199	289	311	314	294
Intangible assets	255	344	292	286	255	241	383	394	340	161
Other non-current assets				4.26	2.99	1.97	3.48	10.7	9.28	9.07
Total assets	1,165	1,215	1,324	1,437	1,559	2,210	2,599	2,935	3,021	2,852
Accounts payable	114	126	157	151	143	243	244	293	262	241
Accrued liabilities	52.8	53	52.4	53.9	47.8	59.3	61.3	45.6	44.7	49.2
Deferred revenue			3.38	45	35.8	80.3	99.4	122	109	129
Short-term debt	1.27	4.22	26.6	0	0				0	3.73
Total current liabilities	205	212	273	288	276	525	502	565	511	525
Long-term debt	629	572	878	845	804	758	761	763	765	757
Lease liabilities					23.4	28.4	56.6	104	157	137
Other non-current liabilities	18.6	21	16.5	13	11.9	15.1	13.1	11.7	14.9	14.5
Total liabilities	907	854	1,202	1,204	1,180	1,345	1,349	1,467	1,482	1,454
Total debt	629	572	878	845	804	758	761	773	765	761
Paid-in capital	398	423	458	477	487	507	500	507	509	527
Retained earnings	-113	-42.4	-317	-200	-64.2	389	802	995	1,049	889
Treasury stock	-2.58	-2.58	-2.58	-2.58	-2.58	-2.58	-2.58	0
Other comprehensive income	-26	-18	-16.4	-41.7	-42.6	-28.7	-50.1	-33.9	-19.1	-18
Shareholders' equity	257	361	122	233	378	865	1,250	1,468	1,540	1,398
Total equity	257	361	122	233	378	865	1,250	1,468	1,540	1,398
Total liabilities and equity	1,165	1,215	1,324	1,437	1,559	2,210	2,599	2,935	3,021	2,852
Shares outstanding	62.5	63.3	47.1	47	47.4	46	41.4	37.3	34.9	33.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	58.8	84.6	137	139	152	588	913	690	473	-15.2
Depreciation and amortization	55	54.7	66.9	72.3	74.5	78.6	84.4	116	121	125
Stock-based compensation	21.1	12.8	14.7	11.8	13.1	17	17.2	21.1	20.3	23.6
Deferred income tax	2.56	0.94	-9.01	-0.8	4.48	-43.3	3.05	12.9	3.37	-48
Change in receivables	24.5	-13.4	-44.4	6.03	16.9	-220	17.7	-30.3	72.7	40.2
Change in inventory	-2.44	-10.3	-36.5	9	24.6	-81.5	-161	-42.4	-31.9	37.4
Change in payables	4.06	8.67	31.7	-22	-5.84	98.4	-29	32.3	-37.6	-8.42
Cash from operations	157	122	146	210	249	573	787	808	549	403
Capital expenditures	-16.8	-25.1	-38.5	-34.9	-33.8	-64.5	-136	-219	-150	-107
Acquisitions	0	-184	-3.47	-98	0	-43.2	-308	-83.4	-6.04	0
Cash from investing	-12.9	-206	2.51	-133	-27.5	-98	-443	-302	-154	-85.6
Debt issued					0	798	0	0
Debt repaid					-40	-835	0	0
Stock issued	0.05	12.2	20.1	7.37	-2.97	2.66	-24	-14.4	-17.8	-6.21
Share buybacks	0	-13.9	-412	-24.4	-15	-135	-500	-491	-381	-100
Dividends paid							0	0	-34.5	-44.2
Cash from financing	-23.9	-67.8	-65.9	-78.2	-61.2	-184	-524	-507	-435	-160
Exchange rate effect	-0.16	-2.62	-1.34	-1.66	0.99	1.33	-7.37	0.66	3.86	-1.45
Net change in cash	120	-155	80.9	-3.25	161	292	-188	-0.64	-36.7	155
Free cash flow	140	96.5	107	175	215	508	651	589	399	296
Interest paid	49.9	26.1	39.9	49.9	38.8	23.7	30.5	43.7	47.1	37.3
Income taxes paid	30.9	49.8	41.6	38.7	51	155	380	151	66.4	-5.67

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 26, 2026; growth uses fiscal years. Valuation uses the share price of $94.57 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	20.0%	Gross profit / revenue.
Operating margin	1.3%	Operating income / revenue.
EBITDA margin	5.7%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-7.3%	Pre-tax income / revenue.
Net margin	-5.5%	Net income / revenue.
FCF margin	2.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	4.1%	Cash from operations / revenue.
Return on equity (ROE)	-12.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-5.9%	Net income / average total assets.
Return on invested capital (ROIC)	1.8%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	14.5%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.9%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.1%	Capital expenditures / revenue.
D&A / revenue	4.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-11.0%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-10.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.1%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-37.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-25.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	6.6%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-96.3%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-73.4%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-37.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-80.2%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-51.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-14.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-103.2%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-103.5%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-26.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	-20.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	10.1%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-25.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	-23.1%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	6.6%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	-9.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	3.8%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	29.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-5.6%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	3.1%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	12.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-7.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-8.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-6.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.73x	Current assets / current liabilities.
Quick ratio	1.66x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.62x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.60x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	27.7%	Total debt / total assets.
Liabilities / assets	53.5%	Total liabilities / total assets.
Net debt	$414.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	2.48x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	$967.4M	Current assets - current liabilities.
Goodwill and intangibles / assets	14.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$867.6M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.07x	Revenue / average total assets.
Fixed asset turnover	5.63x	Revenue / average property, plant and equipment.
Inventory turnover	6.03x	Cost of revenue / average inventory.
Days inventory	61 days	365 x average inventory / cost of revenue.
Receivables turnover	5.07x	Revenue / average receivables.
Days sales outstanding	72 days	365 x average receivables / revenue.
Days payables	35 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	97 days	Days inventory + days sales outstanding - days payables.
Capex / operating cash flow	52.1%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$4.79	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$86.33	Revenue / diluted weighted shares.
FCF per share	$1.69	Free cash flow / diluted weighted shares.
Operating cash flow per share	$3.53	Cash from operations / diluted weighted shares.
Book value per share	$37.79	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$25.69	Tangible book value / shares outstanding.
Cash per share	$10.25	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	77.5%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	0.0%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$3.19B	Share price x shares outstanding.
Enterprise value	$3.61B	Market cap + total debt - cash - short-term investments.
P/S	1.09x	Market cap / revenue.
P/B	2.50x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	3.68x	Market cap / tangible book value, when positive.
P/FCF	55.6x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	26.6x	Market cap / cash from operations, when positive.
EV/Sales	1.23x	Enterprise value / revenue.
EV/EBIT	95.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	21.6x	Enterprise value / EBITDA, when both are positive.
EV/FCF	62.8x	Enterprise value / free cash flow, when both are positive.
FCF yield	1.8%	Free cash flow / market cap.
Earnings yield	-5.1%	Net income / market cap (the inverse of P/E).
Dividend yield	1.4%	Dividends paid over the period / market cap.
Shareholder yield	1.4%	(Dividends paid + share buybacks) / market cap.

What was Atkore Inc.'s revenue in fiscal 2025?

Atkore Inc. reported revenue of $2.85B for fiscal 2025, 11% lower than the year before.

Was Atkore Inc. profitable in fiscal 2025?

No. It reported a net loss of $15.2M.

How much free cash flow did Atkore Inc. generate in fiscal 2025?

Cash from operations of $402.8M minus capital expenditures of $107.1M left free cash flow of $295.7M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Atkore Inc.